Increased Cellular Responsiveness to Epinephrine in Primary Open-Angle Glaucoma

Paul F. Palmberg; Shirley Hajek; Dorothy Cooper; Bernard Becker

doi:10.1001/archopht.1977.04450050133016

Increased Cellular Responsiveness to Epinephrine in Primary Open-Angle Glaucoma

Paul F. Palmberg, Shirley Hajek, Dorothy Cooper, Bernard Becker

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

The concentration of l-epinephrine hydrochloride necessary to inhibit lymphocyte transformation by 50% (I₅₀ value) was determined in vitro for nine patients with primary open-angle glaucoma (POAG) and in seven controls. The lymphocytes of the patients with POAG were significantly (P<.05) more responsive. This result is consistent with the hypothesis that patients with POAG have an increased responsiveness to agents that elevate intracellular cyclic adenosine monophosphate levels.

Original language	English (US)
Pages (from-to)	855-856
Number of pages	2
Journal	Archives of ophthalmology
Volume	95
Issue number	5
DOIs	https://doi.org/10.1001/archopht.1977.04450050133016
State	Published - May 1977
Externally published	Yes

Keywords

Glaucoma
cyclic adenosine monophosphate
epinephrine hydrochloride
lymphocytes

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1001/archopht.1977.04450050133016

Fingerprint Dive into the research topics of 'Increased Cellular Responsiveness to Epinephrine in Primary Open-Angle Glaucoma'. Together they form a unique fingerprint.

Cite this

@article{2a82951fb6384ae3bb0d64049ed28fc9,

title = "Increased Cellular Responsiveness to Epinephrine in Primary Open-Angle Glaucoma",

abstract = "The concentration of l-epinephrine hydrochloride necessary to inhibit lymphocyte transformation by 50% (I50 value) was determined in vitro for nine patients with primary open-angle glaucoma (POAG) and in seven controls. The lymphocytes of the patients with POAG were significantly (P<.05) more responsive. This result is consistent with the hypothesis that patients with POAG have an increased responsiveness to agents that elevate intracellular cyclic adenosine monophosphate levels.",

keywords = "Glaucoma, cyclic adenosine monophosphate, epinephrine hydrochloride, lymphocytes",

author = "Palmberg, {Paul F.} and Shirley Hajek and Dorothy Cooper and Bernard Becker",

year = "1977",

month = may,

doi = "10.1001/archopht.1977.04450050133016",

language = "English (US)",

volume = "95",

pages = "855--856",

journal = "JAMA Ophthalmology",

issn = "2168-6165",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - Increased Cellular Responsiveness to Epinephrine in Primary Open-Angle Glaucoma

AU - Palmberg, Paul F.

AU - Hajek, Shirley

AU - Cooper, Dorothy

AU - Becker, Bernard

PY - 1977/5

Y1 - 1977/5

N2 - The concentration of l-epinephrine hydrochloride necessary to inhibit lymphocyte transformation by 50% (I50 value) was determined in vitro for nine patients with primary open-angle glaucoma (POAG) and in seven controls. The lymphocytes of the patients with POAG were significantly (P<.05) more responsive. This result is consistent with the hypothesis that patients with POAG have an increased responsiveness to agents that elevate intracellular cyclic adenosine monophosphate levels.

AB - The concentration of l-epinephrine hydrochloride necessary to inhibit lymphocyte transformation by 50% (I50 value) was determined in vitro for nine patients with primary open-angle glaucoma (POAG) and in seven controls. The lymphocytes of the patients with POAG were significantly (P<.05) more responsive. This result is consistent with the hypothesis that patients with POAG have an increased responsiveness to agents that elevate intracellular cyclic adenosine monophosphate levels.

KW - Glaucoma

KW - cyclic adenosine monophosphate

KW - epinephrine hydrochloride

KW - lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=0017610189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017610189&partnerID=8YFLogxK

U2 - 10.1001/archopht.1977.04450050133016

DO - 10.1001/archopht.1977.04450050133016

M3 - Article

C2 - 193479

AN - SCOPUS:0017610189

VL - 95

SP - 855

EP - 856

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 5

ER -